TSPO levels were higher in leukemic cells compared with the lymphocytes of healthy individuals at T0; however, six months after treatment commenced, the present study identified a decrease in the TSPO/mitochondria ratio in 24/30 CLL patients to resemble that of the healthy controls. This evidence concerns the gene TSPO and B-cell chronic lymphocytic leukemia.